• • Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL Steripak plastic ampule, 5 count, NDC 63323-0288-10
  • Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL vial, 25 count, NDC 63323-0288-11
  • Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0288-20
  • Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 25 count, NDC 63323-0288-21
  • Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0285-65
  • Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL premixed bag, 1 count, NDC 63323-0285-61
  • Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0285-64
  • Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL premixed bag, 1 count, NDC 63323-0285-63
  • Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0286-20
  • Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL vial, 25 count, NDC 63323-0286-23
  • Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL Steripak plastic ampule, 5 count, NDC 63323-0286-31
  • Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0287-20
  • Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL vial, 25 count, NDC 63323-0287-21
  • Ropivacaine injection, Akorn, 5 mg/mL, 30 mL vial, 1 count, NDC 17478-0081-30
  • Ropivacaine injection, AuroMedics, 10 mg/mL, 10 mL vial, 25 count, NDC 55150-0200-10
  • Ropivacaine injection, AuroMedics, 10 mg/mL, 20 mL vial, 25 count, NDC 55150-0201-20
  • Ropivacaine injection, AuroMedics, 2 mg/mL, 100 mL infusion bottle, 25 count, NDC 55150-0196-99
  • Ropivacaine injection, AuroMedics, 2 mg/mL, 20 mL vial, 25 count, NDC 55150-0195-20
  • Ropivacaine injection, AuroMedics, 5 mg/mL, 20 mL vial, 25 count, NDC 55150-0197-20
  • Ropivacaine injection, AuroMedics, 5 mg/mL, 30 mL vial, 25 count, NDC 55150-0198-30
  • Ropivacaine injection, AuroMedics, 7.5 mg/mL, 20 mL vial, 25 count, NDC 55150-0199-20
  • Ropivacaine injection, Pfizer, 10 mg/mL, 10 mL vial, 10 count, NDC 00409-9303-10
  • Ropivacaine injection, Pfizer, 10 mg/mL, 20 mL vial, 10 count, NDC 00409-9303-20
  • Ropivacaine injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-9300-10
  • Ropivacaine injection, Pfizer, 2 mg/mL, 20 mL vial, 10 count, NDC 00409-9300-20
  • Ropivacaine injection, Pfizer, 5 mg/mL, 30 mL vial, 10 count, NDC 00409-9301-30
  • Ropivacaine injection, Pfizer, 7.5 mg/mL, 20 mL vial, 10 count, NDC 00409-9302-20

• • Akorn has ropivacaine on shortage due to increased demand.
  • AuroMedics did not provide a reason for the shortage.
  • Fresenius Kabi has Naropin on shortage due to increased demand and manufacturing delays.
  • Pfizer has ropivacaine on shortage due to manufacturing delays.

• • Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL Steripak plastic ampule, 5 count, NDC 63323-0285-10
  • Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 25 count, NDC 63323-0285-13
  • Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0285-20
  • Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 25 count, NDC 63323-0285-23
  • Naropin injection, Fresenius Kabi, 5 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0286-00
  • Naropin injection, Fresenius Kabi, 5 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0286-63
  • Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL vial, 25 count, NDC 63323-0286-35

Estimated Resupply Dates

• • Akorn has ropivacaine 2 mg/mL 30 mL vials on back order and the company cannot estimate a release date.
  • AuroMedics has ropivcaine 2 mg/mL 20 mL vials and 100 mL bottles, 5 mg/mL 20 mL and 30 mL vials, 7.5 mg/mL 20 mL vials, and 10 mg/mL 10 mL and 20 mL vials on intermittent back order and the company is releasing product as it becomes available.
  • Pfizer has ropivacaine 2 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of September 2018 for the 10 mL vials and May 2018 for the 20 mL vials. The 5 mg/mL 30 mL vials are on back order and the company estimates a release date of May 2018. The 7.5 mg/mL 20 mL vials are on back order and the company estimates a release date of July 2018. The 10 mg/mL 10 mL and 20 mL vials are on back order and the company estimates a release date of September 2018 for the 10 mL vials and May 2018 for the 20 mL vials.
  • Fresenius Kabi has Naropin 2 mg/mL 100 mL and 200 mL bottles on back order and the company estimates a release date of late-April 2018 for the 100 mL bottles and early-May 2018 for the 200 mL bottles. The 2 mg/mL 100 mL and 200 mL premixed bags are on back order and the company estimates a release date of mid-May 2018. The 5 mg/mL 20 mL vials are on back order and the company estimates a release date of early-May 2018. The 5 mg/mL 20 mL and 30 mL Steripak ampules are on back order and the company estimates a release date of mid-May 2018 for the 20 mL ampules and mid-June 2018 for the 30 mL ampules. The 7.5 mg/mL 20 mL vials are on back order and the company estimates a release date of late-April 2018. The 7.5 mg/mL 20 mL Steripak ampules are on back order and the company estimates a release date of mid-May 2018. The 10 mg/mL 10 mL and 20 mL vials are on back order and the company estimates a release date of early-May 2018 for the 10 mL vials and early-May 2018 for the 20 mL vials. The 10 mg/mL 10 mL and 20 mL Steripak ampules are on back order and the company estimates a release date of mid-May 2018 for the 10 mL ampules and late-May 2018 for the 20 mL ampules. Check wholesalers for inventory.